FDA Amends Animal Drug Regulations for New Sponsors of Griseofulvin, Levamisole, and Oxytetracycline

Summary

The US Food and Drug Administration (FDA) has updated its regulations to reflect a change in sponsor for five abbreviated new animal drug applications (ANADAs) for griseofulvin powder, levamisole hydrochloride powder, and oxytetracycline hydrochloride powder, from Teva Animal Health, Inc. to Cross Vetpharm Group, Ltd.